Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122791
Filing Date
2024-11-07
Accepted
2024-11-07 07:15:21
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rptx-20240930.htm   iXBRL 10-Q 1985665
2 EX-5.1 rptx-ex5_1.htm EX-5.1 17272
3 EX-10.1 rptx-ex10_1.htm EX-10.1 38370
4 EX-10.2 rptx-ex10_2.htm EX-10.2 337361
5 EX-31.1 rptx-ex31_1.htm EX-31.1 15904
6 EX-31.2 rptx-ex31_2.htm EX-31.2 15873
7 EX-32.1 rptx-ex32_1.htm EX-32.1 13213
8 GRAPHIC img194145105_0.jpg GRAPHIC 88541
  Complete submission text file 0000950170-24-122791.txt   8355562

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rptx-20240930.xsd EX-101.SCH 970186
69 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20240930_htm.xml XML 1438184
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 241433148
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)